ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

DOCS Dr. Martens Plc

71.65
2.90 (4.22%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Dr. Martens Plc LSE:DOCS London Ordinary Share GB00BL6NGV24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.90 4.22% 71.65 70.55 71.00 71.95 69.05 70.00 3,315,666 16:35:14
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Footwear-wholesale 877.1M 69.2M 0.0719 25.31 661.36M
Dr. Martens Plc is listed in the Footwear-wholesale sector of the London Stock Exchange with ticker DOCS. The last closing price for Dr. Martens was 68.75p. Over the last year, Dr. Martens shares have traded in a share price range of 62.00p to 162.00p.

Dr. Martens currently has 961,972,102 shares in issue. The market capitalisation of Dr. Martens is £661.36 million. Dr. Martens has a price to earnings ratio (PE ratio) of 25.31.

Dr. Martens Share Discussion Threads

Showing 726 to 749 of 750 messages
Chat Pages: 30  29  28  27  26  25  24  23  22  21  20  19  Older
DateSubjectAuthorDiscuss
16/7/2024
14:52
Burberry's issues are very different from Docs. High-end consumer brands have pushed prices beyond inflation for so long that many buyers have said enough. Also, BRBY was trying to elevate the brand to Dior and Versace levels and that has not worked.

I own a BRBY trench coat that cost me £120 25 years ago (as did many colleagues where I worked). That same coat now costs £1,500. Docs pricing is not out of whack with the price of other branded boots (Blundstones (a little more), Birkenstocks (more expensive) Russell and Bromley (even more expensive) and the price points are accessible.

In terms of Asian exposure, Japan and S Korea are performing well (atm) and they closed their operations in China. BRBY is particularly exposed to the latter in terms of direct sales and London, where the duty-free sales benefit was dumped by the Tories (another Brexit benefit).

Docs problems are in the US where the brand is less well established and the market is not as deep as management anticpated.

mr5k
16/7/2024
12:32
Promblem is that even Burberry are suffering in Asia, and I cannot see DOCS not falling to the same fate.

All these ols takeover rumours have died, like I expected them to be, nothing more than wheeze to unload stocks by some I assume.

DYOR but look forward to the next update on sales decline.

clocktower
12/7/2024
10:08
Superdry moving to JP Jenkins platform. Says it all. This is vastly overvalued. Even Mike Ashley wouldn't be interested at 20 pence
imjustdandy
12/7/2024
08:19
Finished - this is on the way out
imjustdandy
02/7/2024
15:03
Another superdry
johndoe23
02/7/2024
14:35
Another end of the road story for British retailers. Just another dead cat bounce before breaking to fresh lows, dire and a one trick pony, who the hell wears this rubbish nowadays, fashion is very fickle and treacherous as an investment, most fashion house don’t survive with deeper pockets. Price target 0p
ny boy
12/6/2024
16:55
I think it is safe to short this again, as no bid looks like coming, and maybe the rumor was a scam to unload a pile of stock at a far higher value than it is really worth.

The negatives - Debt - Poor business in the USA - UK sales slow - China could soon become another Russia.

Bright Spots - Japan for now but I expect the market to change there also.

clocktower
05/6/2024
07:25
RBC RAISES DR. MARTENS PRICE TARGET TO 80 (65) PENCE - 'SECTOR PERFORM'
bigbigdave
04/6/2024
11:14
Will go private for 40 pence or lower
imjustdandy
04/6/2024
11:05
I'd say £370mManagement seem clueless IMO.
disc0dave46
04/6/2024
08:40
Overvalued by 500m
imjustdandy
31/5/2024
13:09
Looks a short, however, some companies have a habit of defying the fundamentals
johndoe23
31/5/2024
09:58
Dil - great minds!
kemche
31/5/2024
09:56
Profit warning again at JD. Next warning here at DR M sees this crumble
imjustdandy
31/5/2024
08:57
Wow kemche great minds think alike. I got tons of those on your list too.

:-)

dil 21
31/5/2024
08:32
You can buy shag loads below the offer
imjustdandy
31/5/2024
08:24
Basket case looking at the balance sheet. 30 is fair value. 85 is nonsense
imjustdandy
30/5/2024
14:33
Just because I have invested in stellar companies like RTOP, SLYME, VRS, UKOG, RRR, CRCL, VAST, ZED, ECOB, CHLL, TOM, BIDS etc does not give you the right to laugh at me.
kemche
30/5/2024
13:39
Interesting comp chart Birkenstock vs Dr.Martens
viking24
30/5/2024
13:09
what sales figure are you working on to get 300m profit?
tiger

castleford tiger
30/5/2024
10:15
Look at birkenstock, market cap, their sales, profits and debt.
Docs look very cheap compared.
I think them or A&F will be the types of buyer here.
I don't think many designers are asset heavy, its about their brand and its perceived value.
Anyway, whether you buy or not, that's personal choice in investing i guess.

And in section 28 of the rns, see the leases amounts, half the net debt is made up of leases, personally I don't see them as typical debt, more a cost of doing business, they got a lot of retail outlets, etc.
Net debt is just calculated by subtracting total cash and cash equiv from short and long term debt (which Inc's leases).
Net debt isn't always a good indicator of the health of a company IMO. it doesn't show the whole story.

Yes sales are down and profits are vulnerable for the next year or so, but that attracts vultures, and if not, in a couple of years all will be cool IMO with EBITDA north of £300m IMO. and EBIT north of £250m.

hamhamham1
30/5/2024
09:57
The 100m is an historic profit and if revenue is down 20% its likley that a loss maybe reported in the first half.

Huge increase in debt to 357 m that will be costing £25m in charges.

I cannot see a valuation of a billion based on the current outlook.

There is still about 30% of the shares with the PE company that floated this off as well.

Its going to be a hell of a task turning this round.

Market cap wants to be 300/400m maximum because the balance sheet is very light on real assets.

Not for me but a bid could save the day.

castleford tiger
30/5/2024
09:33
Kemche

£100m profit before tax on a bad year, basketcase? Hilarious.

So you're invested in the likes of UKOG and VAST who never make a profit and just promise jam tomorrow, both of those will suck your money up and leave you poor.
Keep it up ;)

hamhamham1
30/5/2024
09:19
Still a basketcase.
kemche
Chat Pages: 30  29  28  27  26  25  24  23  22  21  20  19  Older

Your Recent History

Delayed Upgrade Clock